GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 296 filers reported holding GUARDANT HEALTH INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $342,802 | +5.9% | 11,568 | +28.0% | 0.00% | 0.0% |
| Q2 2023 | $323,697 | +73.6% | 9,036 | +13.6% | 0.00% | – |
| Q1 2023 | $186,441 | -11.7% | 7,956 | +2.3% | 0.00% | – |
| Q4 2022 | $211,032 | -59.6% | 7,774 | -20.1% | 0.00% | -100.0% |
| Q3 2022 | $523,000 | +47.3% | 9,724 | +10.6% | 0.00% | 0.0% |
| Q2 2022 | $355,000 | -94.8% | 8,795 | +6.4% | 0.00% | -92.3% |
| Q1 2022 | $6,818,000 | +626.1% | 8,264 | -12.0% | 0.01% | +550.0% |
| Q4 2021 | $939,000 | -39.5% | 9,387 | -24.5% | 0.00% | -33.3% |
| Q3 2021 | $1,552,000 | +1.1% | 12,433 | +0.6% | 0.00% | 0.0% |
| Q2 2021 | $1,535,000 | -8.9% | 12,357 | +12.0% | 0.00% | -25.0% |
| Q1 2021 | $1,685,000 | +11.4% | 11,032 | -6.0% | 0.00% | 0.0% |
| Q4 2020 | $1,513,000 | -53.1% | 11,739 | -59.4% | 0.00% | -60.0% |
| Q3 2020 | $3,224,000 | +268.5% | 28,909 | +168.4% | 0.01% | +233.3% |
| Q2 2020 | $875,000 | -23.5% | 10,772 | -77.8% | 0.00% | -40.0% |
| Q1 2020 | $1,144,000 | – | 48,451 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |